chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Pain
Clinical narrative: Swelling of right eye; pain; Redness; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Swelling of right eye), PAIN (pain) and ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced EYE SWELLING (Swelling of right eye), PAIN (pain) and ERYTHEMA (Redness). At the time of the report, EYE SWELLING (Swelling of right eye), PAIN (pain) and ERYTHEMA (Redness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-010991, MOD-2021-010991 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional information received reporter details updated.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided by reporter.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Urinary tract infection
Clinical narrative: diarrhea; urinary tract infection; general body pain; This spontaneous case was reported by a physician and describes the occurrence of URINARY TRACT INFECTION (urinary tract infection), ABDOMINAL PAIN (general body pain) and DIARRHOEA (diarrhea) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 003A21A) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis and Crohn's disease.    The patient's past medical history included Fibromyalgia in November 2020, Clostridium difficile infection in December 2020, Tiredness from 30-Mar-2021 to 01-Apr-2021, Constipation on 30-Mar-2021 and General body pain from 30-Mar-2021 to 01-Apr-2021. Concurrent medical conditions included Drug allergy (manifested by hives), Allergy to antibiotic (flagyl allergy manifested by diarrhea), Ankylosing spondylitis, Blood pressure high, Anxiety, Bloating, Insomnia, Depression, Restless leg syndrome, Asthma, Food allergy (apple juice allergy manifested by diarrhea and itching), Crohn's disease and Rheumatoid arthritis. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and FLUTICASONE for Allergy, GABAPENTIN for Ankylosing spondylitis, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma, ETHINYLESTRADIOL, NORGESTIMATE (SPRINTEC) for Birth control, SIMETICONE (GAS X) for Bloating, PROPRANOLOL (PROPANOLOL [PROPRANOLOL]) for Blood pressure high and Anxiety, ARIPIPRAZOLE (ABILIFY) for Depression, CELECOXIB for Fibromyalgia, TRAZODONE for Insomnia, LACTOBACILLUS ACIDOPHILUS (FLORASTOR [LACTOBACILLUS ACIDOPHILUS]) for Probiotic therapy, ROPINIROLE HYDROCHLORIDE (REQUIP) for Restless leg syndrome.   In March 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced URINARY TRACT INFECTION (urinary tract infection). In March 2021, the patient experienced ABDOMINAL PAIN (general body pain). On an unknown date, the patient experienced DIARRHOEA (diarrhea). The patient was treated with CEFPODOXIME at an unspecified dose and frequency. On 30-Mar-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, URINARY TRACT INFECTION (urinary tract infection) and ABDOMINAL PAIN (general body pain) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Reaction to first dose of Moderna Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of ADVERSE REACTION (Reaction to first dose of Moderna Vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Reaction to first dose of Moderna Vaccine). At the time of the report, ADVERSE REACTION (Reaction to first dose of Moderna Vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concominant medications were not reported.  Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Fatigue, Feeling abnormal
Clinical narrative: weakness; Headache; Fever 103.5; Extreme fatigue; Strong shoulder pain; chills; Injection site pain; Brain fog; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog), ASTHENIA (weakness), HEADACHE (Headache), PYREXIA (Fever 103.5) and FATIGUE (Extreme fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Palpitation in 2016. Previously administered products included for an unreported indication: SHINGRIX (second shingrix 50mcg vaccination) in January 2020. Concurrent medical conditions included Thyroid disorder NOS since 2002, Blood pressure high since 2017 and High cholesterol since 2012. Concomitant products included LOSARTAN and ACETYLSALICYLIC ACID (ASPIRIN 81) for Blood pressure high, SIMVASTATIN for High cholesterol, LEVOTHYROXINE for Hypothyroidism, ATENOLOL for Palpitation.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced FEELING ABNORMAL (Brain fog), HEADACHE (Headache), PYREXIA (Fever 103.5), FATIGUE (Extreme fatigue), ARTHRALGIA (Strong shoulder pain), CHILLS (chills) and INJECTION SITE PAIN (Injection site pain). On 05-Mar-2021, the patient experienced ASTHENIA (weakness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Mar-2021, FEELING ABNORMAL (Brain fog), HEADACHE (Headache), PYREXIA (Fever 103.5), FATIGUE (Extreme fatigue), ARTHRALGIA (Strong shoulder pain), CHILLS (chills) and INJECTION SITE PAIN (Injection site pain) had resolved with sequelae. At the time of the report, ASTHENIA (weakness) had resolved with sequelae.            This case was linked to MOD-2021-019707 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Pyrexia
Clinical narrative: weakness; Headache; Fever 103.5; Extreme fatigue; Strong shoulder pain; chills; Injection site pain; Brain fog; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog), ASTHENIA (weakness), HEADACHE (Headache), PYREXIA (Fever 103.5) and FATIGUE (Extreme fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Palpitation in 2016. Previously administered products included for an unreported indication: SHINGRIX (second shingrix 50mcg vaccination) in January 2020. Concurrent medical conditions included Thyroid disorder NOS since 2002, Blood pressure high since 2017 and High cholesterol since 2012. Concomitant products included LOSARTAN and ACETYLSALICYLIC ACID (ASPIRIN 81) for Blood pressure high, SIMVASTATIN for High cholesterol, LEVOTHYROXINE for Hypothyroidism, ATENOLOL for Palpitation.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced FEELING ABNORMAL (Brain fog), HEADACHE (Headache), PYREXIA (Fever 103.5), FATIGUE (Extreme fatigue), ARTHRALGIA (Strong shoulder pain), CHILLS (chills) and INJECTION SITE PAIN (Injection site pain). On 05-Mar-2021, the patient experienced ASTHENIA (weakness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Mar-2021, FEELING ABNORMAL (Brain fog), HEADACHE (Headache), PYREXIA (Fever 103.5), FATIGUE (Extreme fatigue), ARTHRALGIA (Strong shoulder pain), CHILLS (chills) and INJECTION SITE PAIN (Injection site pain) had resolved with sequelae. At the time of the report, ASTHENIA (weakness) had resolved with sequelae.            This case was linked to MOD-2021-019707 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe  explosive Diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included TOFACITINIB CITRATE (XELJANZ XR) for Rheumatoid arthritis. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced DIARRHOEA (Severe  explosive Diarrhea). On 12-Jan-2021, DIARRHEA (Severe  explosive Diarrhea) had resolved. Patient stopped consuming Xeljanz XR for 5 days prior to 2nd dose of Moderna COVID vaccine and did not experienced any reactions after the 2nd dose of vaccine. Patient had severe exploding Diarrhea 12 hours after the administration of 1st dose of Moderna vaccine, which lasted for 2 hours then recovered.
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This spontaneous case was reported by a patient and describes the occurrence of VERTIGO (vertigo) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) outcome was unknown.            There was no treatment medication reported by the reporter.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Charlie horses in his feet and calves; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Charlie horses in his feet and calves) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Charlie horses in his feet and calves). At the time of the report, MUSCLE SPASMS (Charlie horses in his feet and calves) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination Adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination Adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination Adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination Adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Non-significant FU: enquiry regarding case number On 30-Jun-2021: Non-significant FU: enquiry
Sex: F
Vaccine: COVID19
Symptoms: Anger, Chills, Depression, Fatigue, Hypersomnia
Clinical narrative: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms), IRRITABILITY (Severe irritability), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 011L20A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy, Drug allergy and Hypothyroidism (T3 and T4 are normal) since 2012. Concomitant products included LEVOTHYROXINE for Hypothyroidism, MULTIVITAMIN [VITAMINS NOS] and EVENING PRIMROSE OIL [OENOTHERA BIENNIS OIL] for an unknown indication. On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms) with PAIN (Body aches), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Severe fatigue), IRRITABILITY (Severe irritability) with ANGER (angry) and DEPRESSION (depressed), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours). On 22-Jan-2021, INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms), IRRITABILITY (Severe irritability), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms), IRRITABILITY (Severe irritability), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours) to be possibly related. This case was linked to MOD-2021-024838.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Irritability, Pain, Pyrexia, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms), IRRITABILITY (Severe irritability), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 011L20A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy, Drug allergy and Hypothyroidism (T3 and T4 are normal) since 2012. Concomitant products included LEVOTHYROXINE for Hypothyroidism, MULTIVITAMIN [VITAMINS NOS] and EVENING PRIMROSE OIL [OENOTHERA BIENNIS OIL] for an unknown indication. On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms) with PAIN (Body aches), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Severe fatigue), IRRITABILITY (Severe irritability) with ANGER (angry) and DEPRESSION (depressed), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours). On 22-Jan-2021, INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms), IRRITABILITY (Severe irritability), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered INFLUENZA LIKE ILLNESS (overall feeling of coming down with the flu symptoms), IRRITABILITY (Severe irritability), VACCINATION SITE PAIN (Sore arm at the injection site) and HYPERSOMNIA (slept for 36 hours) to be possibly related. This case was linked to MOD-2021-024838.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of asthenia (too weak) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jan 30, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 1, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced asthenia (too weak). At the time of the report, asthenia (too weak) outcome: unknown. Treatment details not provided. This case linked to MOD-2021-013278 (patient link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: sore arm; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and VACCINATION SITE PAIN (Vaccination site pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010mz0a and 039k20a) for COVID-19 vaccination.     Concurrent medical conditions included Vegetable allergy (Shrimp).   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, PAIN IN EXTREMITY (sore arm) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.            Concomitant product was not provided by the  reporter                                                                                          The patient had numb check from the first dose reaction, the patient had second dose reaction of sore arm the day after the shot.    This case was linked to MOD-2021-159363 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up received on 21-JUN-2021 contains No New Information
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Hyperhidrosis, Limb injury
Clinical narrative: Skin lesion; arm injury; Shortness of breath; sexual dysfunction; itching all over; open wound; sweating; skin pain; pain in extremity; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (Skin lesion), LIMB INJURY (arm injury), DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction) and PRURITUS (itching all over) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN LESION (Skin lesion), LIMB INJURY (arm injury), DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction), PRURITUS (itching all over), WOUND (open wound), HYPERHIDROSIS (sweating), PAIN OF SKIN (skin pain), PAIN IN EXTREMITY (pain in extremity), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). The patient was treated with ADALIMUMAB (HUMIRA) at a dose of 80 mg. At the time of the report, SKIN LESION (Skin lesion), LIMB INJURY (arm injury) and WOUND (open wound) had not resolved, DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction), HYPERHIDROSIS (sweating), PAIN OF SKIN (skin pain), HEADACHE (headache) and CHILLS (chills) outcome was unknown and PRURITUS (itching all over), PAIN IN EXTREMITY (pain in extremity) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pain of skin, Pruritus, Pyrexia, Sexual dysfunction
Clinical narrative: Skin lesion; arm injury; Shortness of breath; sexual dysfunction; itching all over; open wound; sweating; skin pain; pain in extremity; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (Skin lesion), LIMB INJURY (arm injury), DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction) and PRURITUS (itching all over) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN LESION (Skin lesion), LIMB INJURY (arm injury), DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction), PRURITUS (itching all over), WOUND (open wound), HYPERHIDROSIS (sweating), PAIN OF SKIN (skin pain), PAIN IN EXTREMITY (pain in extremity), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). The patient was treated with ADALIMUMAB (HUMIRA) at a dose of 80 mg. At the time of the report, SKIN LESION (Skin lesion), LIMB INJURY (arm injury) and WOUND (open wound) had not resolved, DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction), HYPERHIDROSIS (sweating), PAIN OF SKIN (skin pain), HEADACHE (headache) and CHILLS (chills) outcome was unknown and PRURITUS (itching all over), PAIN IN EXTREMITY (pain in extremity) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Skin lesion, Wound
Clinical narrative: Skin lesion; arm injury; Shortness of breath; sexual dysfunction; itching all over; open wound; sweating; skin pain; pain in extremity; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (Skin lesion), LIMB INJURY (arm injury), DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction) and PRURITUS (itching all over) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN LESION (Skin lesion), LIMB INJURY (arm injury), DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction), PRURITUS (itching all over), WOUND (open wound), HYPERHIDROSIS (sweating), PAIN OF SKIN (skin pain), PAIN IN EXTREMITY (pain in extremity), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). The patient was treated with ADALIMUMAB (HUMIRA) at a dose of 80 mg. At the time of the report, SKIN LESION (Skin lesion), LIMB INJURY (arm injury) and WOUND (open wound) had not resolved, DYSPNOEA (Shortness of breath), SEXUAL DYSFUNCTION (sexual dysfunction), HYPERHIDROSIS (sweating), PAIN OF SKIN (skin pain), HEADACHE (headache) and CHILLS (chills) outcome was unknown and PRURITUS (itching all over), PAIN IN EXTREMITY (pain in extremity) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not provided.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient was 17; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 17) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044b21a and 033c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 17). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 17) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: arm was somewhat sore; mild headache; felt mildly tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was somewhat sore), HEADACHE (mild headache) and FATIGUE (felt mildly tired) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 042L20A) for COVID-19 vaccination.     The patient had no other chronic or long-standing health conditions. The patient had no history of anaphylaxis, hypersensitivity reactions, hives or urticaria, asthma and hay fever.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was somewhat sore), HEADACHE (mild headache) and FATIGUE (felt mildly tired). At the time of the report, PAIN IN EXTREMITY (arm was somewhat sore) had resolved and HEADACHE (mild headache) and FATIGUE (felt mildly tired) outcome was unknown.            The patient had no acute illnesses at the time of vaccination and up to one month before. The patient had these events after her second dose. Her arm was somewhat sore for two days. The events did not cause her to seek medical care. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-027542 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-027542:First dose case
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain
Clinical narrative: Flares; Pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-May-2021 and was forwarded to Moderna on 21-May-2021.    This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (Flares) and PAIN (Pain) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Flares) and PAIN (Pain). At the time of the report, ERYTHEMA (Flares) and PAIN (Pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache; Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis. Concomitant products included ADALIMUMAB (HUMIRA) for Psoriatic arthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, HEADACHE (Headache) and PYREXIA (Fever) had resolved. Not Provided          It was reported that the patient received both doses of vaccination in 2021.  No concomitant medications reported.  Patient experienced headache and fever in 2021.  Treatment of the events were not reported.
Sex: M
Vaccine: COVID19
Symptoms: Hangover, Hunger, Irritability, Somnolence
Clinical narrative: Irritable; Live hangover; Sleepy, ate his food and again sleepy; Hungry; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy, ate his food and again sleepy), HUNGER (Hungry), HANGOVER (Live hangover) and IRRITABILITY (Irritable) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced SOMNOLENCE (Sleepy, ate his food and again sleepy) and HUNGER (Hungry). On 09-Apr-2021, the patient experienced HANGOVER (Live hangover). On an unknown date, the patient experienced IRRITABILITY (Irritable). At the time of the report, SOMNOLENCE (Sleepy, ate his food and again sleepy), HUNGER (Hungry), HANGOVER (Live hangover) and IRRITABILITY (Irritable) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-044103, MOD-2021-044103 (Patient Link).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Product dose omission issue
Clinical narrative: missed 2 - 3 doses; new swollen joints; worsening joint pain; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed 2 - 3 doses), JOINT SWELLING (new swollen joints) and ARTHRALGIA (worsening joint pain) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed 2 - 3 doses), JOINT SWELLING (new swollen joints) and ARTHRALGIA (worsening joint pain). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed 2 - 3 doses), JOINT SWELLING (new swollen joints) and ARTHRALGIA (worsening joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Non- Significant Follow Up- (Contact Info Updated- Name, address, phone of pharmacist)
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain
Clinical narrative: hard at the injection site; my arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hard at the injection site) and VACCINATION SITE PAIN (my arm was sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (hard at the injection site) and VACCINATION SITE PAIN (my arm was sore). At the time of the report, VACCINATION SITE INDURATION (hard at the injection site) and VACCINATION SITE PAIN (my arm was sore) had resolved.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-160993, MOD-2021-044414, MOD-2021-044414 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Eye allergy, Eye swelling
Clinical narrative: Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased; Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased; This spontaneous case was reported by a patient family member or friend and describes the occurrence of EYE ALLERGY (Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased) and EYE SWELLING (Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EYE ALLERGY (Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased) and EYE SWELLING (Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased). At the time of the report, EYE ALLERGY (Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased) and EYE SWELLING (Received the 2nd and had an allergic reaction on  eye, it was swollen and has decreased) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD21-093411, MOD21-093540, US-MODERNATX, INC.-MOD-2021-162458 (E2B Linked Report).; Sender's Comments:  MOD21-093411:Wife case MOD21-093540: US-MODERNATX, INC.-MOD-2021-162458:Husband's case
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Vomiting
Clinical narrative: headache; nausea; vomiting; chills; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and VOMITING (vomiting) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced CHILLS (chills). On 18-May-2021, the patient experienced HEADACHE (headache), NAUSEA (nausea) and VOMITING (vomiting). At the time of the report, CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: A 14 year boy received first dose of Moderna Covid-19 Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year boy received first dose of Moderna Covid-19 Vaccine) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year boy received first dose of Moderna Covid-19 Vaccine). On 14-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year boy received first dose of Moderna Covid-19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported Treatment information was not provided    Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Non significant follow up
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Nausea, Vaccination site pain
Clinical narrative: Back hurts; arm is sore; she is nauseous; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back hurts), VACCINATION SITE PAIN (arm is sore) and NAUSEA (she is nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back hurts), VACCINATION SITE PAIN (arm is sore) and NAUSEA (she is nauseous). At the time of the report, BACK PAIN (Back hurts), VACCINATION SITE PAIN (arm is sore) and NAUSEA (she is nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Contusion
Clinical narrative: horrible bruising on her legs; Elbowand shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (horrible bruising on her legs) and ARTHRALGIA (Elbowand shoulder pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONTUSION (horrible bruising on her legs) and ARTHRALGIA (Elbowand shoulder pain). At the time of the report, CONTUSION (horrible bruising on her legs) and ARTHRALGIA (Elbowand shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm getting sore/moves around and may be higher than ijection site/pain in left arm/Righ arm  sore all the time/Left arm pain is mild adn goes away/Pain happens when reaches up; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore) and PAIN IN EXTREMITY (arm getting sore/moves around and may be higher than ijection site/pain in left arm/Righ arm  sore all the time/Left arm pain is mild adn goes away/Pain happens when reaches up) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012-M20A and 039-k204) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (arm sore). On 07-May-2021, the patient experienced PAIN IN EXTREMITY (arm getting sore/moves around and may be higher than ijection site/pain in left arm/Righ arm  sore all the time/Left arm pain is mild adn goes away/Pain happens when reaches up). On 10-Feb-2021, PAIN IN EXTREMITY (arm sore) had resolved. At the time of the report, PAIN IN EXTREMITY (arm getting sore/moves around and may be higher than ijection site/pain in left arm/Righ arm  sore all the time/Left arm pain is mild adn goes away/Pain happens when reaches up) outcome was unknown.            Concomitant medicines include Cholesterol Medicines, Blood pressure  Medicines, Prostrate medicines  treatment medicines were not reported   This case was linked to MOD-2021-161412 (Patient Link).
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in left arm; Arm has been getting sore/right arm, that's the one that is sore all the time; Arm got sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm has been getting sore/right arm, that's the one that is sore all the time), PAIN IN EXTREMITY (Pain in left arm) and PAIN IN EXTREMITY (Arm got sore) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012-M20A and 039-k204) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol and Blood pressure.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm got sore). On 07-May-2021, the patient experienced PAIN IN EXTREMITY (Arm has been getting sore/right arm, that's the one that is sore all the time). On 20-May-2021, the patient experienced PAIN IN EXTREMITY (Pain in left arm). On 10-Feb-2021, PAIN IN EXTREMITY (Arm got sore) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm has been getting sore/right arm, that's the one that is sore all the time) had not resolved and PAIN IN EXTREMITY (Pain in left arm) outcome was unknown.            Concomitant medications provided include cholesterol, blood pressure and prostate medications. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable. The patient stated that the pain moves around in the right arm and may be a little higher up than the injection site. The pain in the left arm is mild and kind of goes away and this seems to bother him when he reaches up.   This case was linked to MOD-2021-161382 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No medical history reported.     On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced MYALGIA (Sore arm). The patient was treated with MULTIVITAMINS;MINERALS at an unspecified dose and frequency. At the time of the report, MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication history not provided. No treatment details reported.